logo-loader

OncoSenX

Receive alerts
Market:
PRIVATE
Market Cap:
-
Price
-
Change
-
52 weeks high
-
52 weeks low
-

In brief

OncoSenX is a late stage pre-clinical cancer company headquartered in Seattle, Washington. OncoSenX targets solid tumors based on transcriptional activity using a unique lipid nanoparticle and plasmid DNA.